Danish pharmaceutical company Azanta has appointed a new CEO. His maintask is to pave the way to the European market for Azanta's drug, which the company already launched in some countries by use of untraditional methods.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.